A Multicenter, Prospective, Randomized, Double-Blind Trial of Basiliximab in Heart Transplantation

These pilot results describe the pharmacokinetics of basiliximab and show that basiliximab appears to be tolerated with a similar safety profile to placebo in adult de novo heart transplant recipients. Larger scale clinical trials are feasible and warranted.